Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Morgan Stanley

Benzinga's Top Ratings Upgrades, Downgrades For May 3, 2022

Upgrades

Benzinga

10 Biggest Price Target Changes For Tuesday

Morgan Stanley cut Expedia Group, Inc. (NASDAQ: EXPE) price target from $215 to $210. Expedia shares rose 0.1% to close at $174.81 on Monday.

Benzinga

Looking At AbbVie's Recent Whale Trades

A whale with a lot of money to spend has taken a noticeably bullish stance on AbbVie. Looking at options history for AbbVie (NYSE:ABBV) we detected 10 strange trades.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Morgan Stanley Maintains Equal-Weight Rating for Qorvo: Here's What You Need To Know

Morgan Stanley has decided to maintain its Equal-Weight rating of Qorvo (NASDAQ:QRVO) and lower its price target from $150.00 to $127.00. Shares of Qorvo are trading up 1.94% over the last 24 hours, at $115.99 per share. A move to $127.00 would account for a 9.49% increase from the current…

Benzinga

10 Biggest Price Target Changes For Monday

Morgan Stanley boosted Archer-Daniels-Midland Company (NYSE: ADM) price target from $69 to $94. Archer-Daniels-Midland shares fell 0.5% to $89.10 in pre-market trading.

Benzinga

Here's How Much $100 Invested In Morgan Stanley 10 Years Ago Would Be Worth Today

Morgan Stanley (NYSE:MS) has outperformed the market over the past 10 years by 5.97% on an annualized basis producing an average annual return of 17.53%. Currently, Morgan Stanley has a market capitalization of $143.39 billion.

Benzinga

Why Are Accolade Shares Down Over 40% Today

Accolade Inc (NASDAQ:ACCD) shares plunged almost 50% after disappointing Q4 FY22 earnings and FY23 guidance. Q4 FY22 revenue increased 58% Y/Y to $93.8 million, beating the consensus of $91.57 million. The company reported a wider net loss of $(34.56) million compared to $(4.73) million a year ago. EPS loss came at $(0.51)…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

10 Biggest Price Target Changes For Friday

Morgan Stanley lowered Apple Inc. (NASDAQ: AAPL) price target from $210 to $195. Apple shares fell 2.6% to $159.25 in pre-market trading.

Benzinga

'Long Road Of Rebuilding Begins': PayPal Analysts React To Mixed Q1 Earnings Report

Shares of PayPal Holdings Inc (NASDAQ: PYPL) gained 11% on Thursday after the company reported a revenue beat but cut its 2022 guidance.

Benzinga

How Is The Market Feeling About Morgan Stanley?

Morgan Stanley's (NYSE:MS) short percent of float has risen 8.18% since its last report. The company recently reported that it has 16.68 million shares sold short, which is 1.19% of all regular shares that are available for trading.

Benzinga

Chipotle Can Navigate Food Cost Concerns, Menu Price Increases: 4 Analysts React To Earnings Report

Rising food costs, menu price increases and store growth were the big topics highlighted by analysts who cover restaurant company Chipotle Mexican Grill, Inc. (NYSE: CMG). Here are the key analyst takeaways.

Benzinga

Morgan Stanley Whale Trades Spotted

A whale with a lot of money to spend has taken a noticeably bullish stance on Morgan Stanley. Looking at options history for Morgan Stanley (NYSE:MS) we detected 30 strange trades.

Benzinga

Morgan Stanley Maintains Equal-Weight Rating for Invesco: Here's What You Need To Know

Morgan Stanley has decided to maintain its Equal-Weight rating of Invesco (NYSE:IVZ) and lower its price target from $25.00 to $23.00. Shares of Invesco are trading down 1.26% over the last 24 hours, at $18.79 per share. A move to $23.00 would account for a 22.41% increase from the current…

Benzinga

'Difficult Environment And Tough Comps': Google Analysts React To Disappointing Earnings Report

Alphabet Inc (NASDAQ: GOOG) (NASDAQ: GOOGL) shares traded lower by 3% on Wednesday after the tech giant reported an earnings miss and disappointed the market with its YouTube numbers.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

What Are Whales Doing With IBM

A whale with a lot of money to spend has taken a noticeably bearish stance on IBM. Looking at options history for IBM (NYSE:IBM) we detected 13 strange trades.

Benzinga

6 Microsoft Analysts Praise Q3 Earnings Beat, Azure Acceleration, Office 365 Momentum

Microsoft Corporation (NASDAQ: MSFT) shares traded higher by 7.2% on Wednesday after the company reported an across-the-board earnings beat and demonstrated impressive sales momentum.

Benzinga

Wall Street Banks Slash Chinese Companies' Profit Forecasts - Read Why

Some Wall Street banks slashed their profit estimates for Chinese companies, citing the recent Covid resurgence and subsequent lockdowns, Bloomberg reports. China's Covid Zero policy has dealt a heavy blow to the economy, as stringent restrictions pressure supply chains and chill consumption. A week-long lockdown that shut down much of Shanghai…

Benzinga

Morgan Stanley Bumps Up Enbridge Price Target By ~12%

Enbridge Inc (TSX:ENB) (NYSE:ENB) price target has been raised to C$67 from C$60 by Morgan Stanley analyst Robert Kad. The analyst maintained the Equal Weight rating on the shares Kad is bullish on the midstream sector for the rest of 2022. He expects solid Q1 prints and constructive management outlooks, citing a favorable commodity backdrop.…

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 26, 2022

Upgrades According to Susquehanna, the prior rating for Boyd Gaming Corp (NYSE:BYD) was changed from Neutral to Positive. At the moment, the stock has a 52-week-high of $72.72 and a 52-week-low of $50.38. Boyd Gaming closed at $64.20 at the end of the last trading period.

Benzinga

What To Know About Morgan Stanley's Downgrade of Alnylam Pharmaceuticals

Morgan Stanley downgraded its rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) to Equal-Weight with a price target of $178.00, changing its price target from $210.00 to $178.00. Shares of Alnylam Pharmaceuticals are trading down 4.47% over the last 24 hours, at $159.53 per share.

Benzinga

Morgan Stanley Upgrades Penn National Gaming, Says Barstool Provides 'Unique Customer Acquisition Opportunity'

It's been a brutal year for Penn National Gaming, Inc (NASDAQ: PENN) investors, but the stock got a much-needed boost from a high-profile analyst upgrade on Monday.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2022

Tribune News Service

Musk nears $43 billion deal for Twitter as soon as Monday

Twitter Inc. is in the final stretch of negotiations about a $43 billion sale to Elon Musk that could rank as one of the biggest-ever leveraged buyouts of a listed company, people with knowledge of the matter said, placing an influential blogging platform under control of the world’s richest person.

Benzinga

How Elon Musk Managed to Convince Banks For Financing Proposed Twitter Deal?

Elon Musk disclosed in a filing on Thursday that he has received commitments for $46.5 million in debt financing to buy Twitter, Inc. (NYSE: TWTR).

Asharq Al-Awsat

Musk Says He Has Financing to Take Twitter Buyout Bid to Investors

Elon Musk has lined up $46.5 billion in financing for a possible hostile takeover of Twitter and is "exploring" a direct tender offer to shareholders, according to a securities filing released Thursday. Musk's filing pointed to a $13 billion debt facility from a financing consortium led by Morgan Stanley, a…

1 … 57 58 59 60

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.